Standex International Files 8-K/A Amendment
Ticker: SXI · Form: 8-K/A · Filed: Jan 13, 2025 · CIK: 310354
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Standex filed an amendment to an 8-K, likely correcting or adding details to a prior filing from late October 2024.
AI Summary
Standex International Corporation filed an 8-K/A amendment on January 13, 2025, related to events reported on October 31, 2024. The filing primarily concerns financial statements and exhibits, indicating an update or correction to previously submitted information. The company, incorporated in Delaware, is based in Salem, New Hampshire.
Why It Matters
This filing is an amendment to a previous report, suggesting a need for clarification or correction of information previously disclosed to the public and investors.
Risk Assessment
Risk Level: low — This is a procedural amendment to a previous filing, not a disclosure of new material negative events.
Key Numbers
- 001-07233 — SEC File Number (Identifies the company's filing history with the SEC.)
- 31-0596149 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Standex International Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- October 31, 2024 (date) — Date of earliest event reported
- January 13, 2025 (date) — Filing date
- Salem, New Hampshire (location) — Principal executive offices
FAQ
What specific information is being amended in this 8-K/A filing?
The filing is an amendment to a previous 8-K report and concerns 'Financial Statements and Exhibits', suggesting updates or corrections to these sections.
What was the original date of the event being reported on?
The earliest event reported was on October 31, 2024.
When was this amendment filed with the SEC?
This 8-K/A amendment was filed on January 13, 2025.
What is Standex International Corporation's state of incorporation?
Standex International Corporation is incorporated in Delaware.
Where are Standex International Corporation's principal executive offices located?
The principal executive offices are located at 23 Keewaydin Drive, Salem, New Hampshire.
Filing Stats: 695 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2025-01-13 15:59:13
Key Financial Figures
- $1.50 — ch registered Common Stock , Par Value $1.50 Per Share SXI New York Stock Exchang
Filing Documents
- sxi20250107_8ka.htm (8-K/A) — 30KB
- ex_764411.htm (EX-23.1) — 2KB
- ex_764349.htm (EX-99.1) — 342KB
- ex_764498.htm (EX-99.2) — 231KB
- ex_764554.htm (EX-99.3) — 361KB
- 0001437749-25-000976.txt ( ) — 1178KB
- sxi-20241028.xsd (EX-101.SCH) — 3KB
- sxi-20241028_def.xml (EX-101.DEF) — 11KB
- sxi-20241028_lab.xml (EX-101.LAB) — 15KB
- sxi-20241028_pre.xml (EX-101.PRE) — 11KB
- sxi20250107_8ka_htm.xml (XML) — 3KB
01 – Financial Statements and Exhibits
Item 9.01 – Financial Statements and Exhibits. (a)
Financial statements of business acquired
Financial statements of business acquired. The audited combined financial statements of the Amran/Narayan Group as of and for the year ended December 31, 2023 and the unaudited condensed combined financial statements of the Amran/Narayan Group as of and for the six months ended June 30, 2024 are attached hereto as Exhibit 99.1 and 99.2 and are incorporated herein by reference. (b) Pro forma financial information. The unaudited pro forma condensed combined financial statements of the Company as of and for the Company's fiscal year ended June 30, 2024 giving pro forma effect to the acquisition of the Amran/Narayan Group are attached hereto as Exhibit 99.3 and are incorporated herein by reference. (c) Exhibits. Exhibit No. Description 23.1 Consent of Independent Registered Public Accounting Firm Deloitte & Touche LLP 99.1 Audited combined financial statements of the Amran/Narayan Group as of and for the year ended December 31, 2023 99.2 Unaudited condensed combined financial statements of the Amran/Narayan Group as of and for the six months ended June 30, 2024 99.3 Unaudited pro forma condensed combined financial statements of the Company as of and for the year ended June 30, 2024 giving pro forma effect to the acquisition of the Amran/Narayan Group 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. STANDEX INTERNATIONAL CORPORATION (Registrant) /s/ Ademir Sarcevic Ademir Sarcevic Chief Financial Officer Date: January 13, 2025 Signing on behalf of the registrant and as principal financial officer